Fig. 4From: IVIVC assessment, pharmacokinetic evaluation, and X-ray radiography mapping of Novel Parteck® SRP 80 and hypromellose-loaded LTD4 receptor antagonist chronosystemCorrelation of in-vivo drug absorbed and in-vitro drug release to obtain level-A IVIVC. Data were obtained from the fraction of drug released and the fraction of drug absorbed, and a straight-line graph was plotted. The regression coefficient of more than 0.9 confirmed the level-A IVIVCBack to article page